This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After sharing plans to shutter last summer, Asarina Pharma has managed to sell o...
Bristol Myers Squibb has continued its ruthless cost-cutting push, dropping plan...
The procedure was performed January 25 by surgeons at the Mass General Transplan...
The DNA sequencing giant said it will continue to do business in China as long a...
Researchers have used artificial intelligence to identify 25 new protein compoun...